Joshua B. Cohen - Sep 12, 2024 Form 4 Insider Report for Amylyx Pharmaceuticals, Inc. (AMLX)

Role
Co-Chief Executive Officer, Director
Signature
/s/ Joshua B. Cohen
Stock symbol
AMLX
Transactions as of
Sep 12, 2024
Transactions value $
$54,085
Form type
4
Date filed
9/16/2024, 05:39 PM
Previous filing
Apr 18, 2024
Next filing
Sep 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMLX Common Stock Options Exercise $54.1K +34.4K +1.08% $1.57 3.24M Sep 12, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMLX Stock Option (right to buy) Options Exercise $0 -34.4K -94.89% $0.00 1.86K Sep 12, 2024 Common Stock 34.4K $1.57 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is fully vested and exercisable.